A phase 1 study of denintuzumab mafodotin (SGN-CD19A) in adults with relapsed or refractory B-lineage acute leukemia (B-ALL) and highly aggressive lymphoma Meeting Abstract


Authors: Fathi, A. T.; Borate, U.; DeAngelo, D. J.; O'Brien, M. M.; Trippett, T.; Shah, B. D.; Hale, G. A.; Foran, J. M.; Silverman, L. B.; Tibes, R.; Cramer, S.; Pauly, M.; Kim, S.; Kostic, A.; Huang, X. H.; Pan, Y.; Chen, R.
Abstract Title: A phase 1 study of denintuzumab mafodotin (SGN-CD19A) in adults with relapsed or refractory B-lineage acute leukemia (B-ALL) and highly aggressive lymphoma
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019004128
PROVIDER: wos
Notes: Meeting Abstract: 1328 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos